Skip to form

NanoString GeoMx® as a Key Tool for Immuno-Oncology Drug Discovery

NanoString's GeoMx® Digital Spatial Profiling (DSP) platform has emerged as a key tool in the journey for better immuno-oncology drugs. Recent publications have highlighted research using this transcriptomic assay to analyze the tumor and tumor microenvironment enabling scientists to identify therapeutic targets and molecular biomarkers.

This 15-minute webinar reviews case studies from the literature using GeoMx in IO drug discovery work. Canopy Biosciences is a premier NanoString GeoMx DSP CRO, running research, pre-clinical, and clinical studies using this platform.